Carmen Gravina

Pubblicazioni

Titolo Pubblicato in Anno
Re: Edward Lambert, Emmanuel Chartier-Kastler, Christophe Vaessen, et al. Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.09.025 EUROPEAN UROLOGY 2024
Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist THE JOURNAL OF UROLOGY 2024
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review JOURNAL OF CLINICAL MEDICINE 2023
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries PROSTATE CANCER AND PROSTATIC DISEASES 2023
Medications mostly associated with hematuria: assessment of the EudraVigilance and Food and Drug Administration pharmacovigilance databases entries MINERVA UROLOGY AND NEPHROLOGY 2023
Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies LIFE 2023
Re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008 EUROPEAN UROLOGY FOCUS 2023
Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries MINERVA UROLOGY AND NEPHROLOGY 2023
Trends and incidence of reported events associated with ureteroscopes: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
Metabolic syndrome evaluation improves prostate cancer detection in patients undergoing a repeat biopsy EUROPEAN UROLOGY. SUPPLEMENTS 2023
Trends and incidence of reported events associated with male slings: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
Re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010 EUROPEAN UROLOGY FOCUS 2023
Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort THE PROSTATE 2022
Ureteral wall thickness and distal ureteral density in patients with residual fragments after Ho:YAG laser semi-rigid ureterolithotripsy LASERS IN MEDICAL SCIENCE 2022
Post-voided residual urine ratio as a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: development of a clinical nomogram WORLD JOURNAL OF UROLOGY 2022
Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the Eudra-Vigilance Database MINERVA UROLOGY AND NEPHROLOGY 2022
Ureteral stent encrustation: evaluation of available scores as predictors of a complex surgery MINERVA UROLOGY AND NEPHROLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma